The aim of this study was to compare the efficacy and safety of two treatment regimens: argon
plasma coagulation (APC) alone and APC in combination with sucralfate administered for
chronic hemorrhagic radiation proctopathy.
Phase:
Phase 4
Details
Lead Sponsor:
Maria Sklodowska-Curie Institute - Oncology Center Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology